U.S. FDA approves Clinuvel Pharma's rare genetic disorder treatment

The U.S. Food and Drug Administration said on Tuesday it approved Australian drugmaker Clinuvel Pharmaceuticals Ltd's treatment for a rare inherited disorder that results in skin damage from exposure to light.